Display options
Cite
Bhargava S, McKeever C, Sadoughifar R, et al. Availability of personal protective equipment among dermatologists in the COVID-19 pandemic: Assessment and risk factors in a web-based, global study. Clin Dermatol. 2021;39(3):451-456doi: 10.1016/j.clindermatol.2021.01.008.
Bhargava, S., McKeever, C., Sadoughifar, R., & Kroumpouzos, G. (2021). Availability of personal protective equipment among dermatologists in the COVID-19 pandemic: Assessment and risk factors in a web-based, global study. Clinics in dermatology, 39(3), 451-456. https://doi.org/10.1016/j.clindermatol.2021.01.008
Bhargava, Shashank, et al. "Availability of personal protective equipment among dermatologists in the COVID-19 pandemic: Assessment and risk factors in a web-based, global study." Clinics in dermatology vol. 39,3 (2021): 451-456. doi: https://doi.org/10.1016/j.clindermatol.2021.01.008
Bhargava S, McKeever C, Sadoughifar R, Kroumpouzos G. Availability of personal protective equipment among dermatologists in the COVID-19 pandemic: Assessment and risk factors in a web-based, global study. Clin Dermatol. 2021 May-Jun;39(3):451-456. doi: 10.1016/j.clindermatol.2021.01.008. Epub 2021 Feb 01. PMID: 34518003; PMCID: PMC7849520.
Copy Download .nbib Format: NLM
Share it on

Clin Dermatol. 2021 May-Jun;39(3):451-456. doi: 10.1016/j.clindermatol.2021.01.008. Epub 2021 Feb 01.

Availability of personal protective equipment among dermatologists in the COVID-19 pandemic: Assessment and risk factors in a web-based, global study.

Clinics in dermatology

Shashank Bhargava, Charles McKeever, Roxanna Sadoughifar, George Kroumpouzos

Affiliations

  1. Department of Dermatology, RD Gardi Medical College, Ujjain, India.
  2. Department of Dermatology, University of Panama Medical School and Social Security Hospital, Panama City, Panama.
  3. Bidar Skin Center, Tehran, Iran.
  4. Department of Dermatology, Alpert Medical School, Brown University, Providence, Rhode Island, USA. Electronic address: [email protected].

PMID: 34518003 PMCID: PMC7849520 DOI: 10.1016/j.clindermatol.2021.01.008

Abstract

BACKGROUND: The availability of personal protective equipment (PPE) among dermatologists during the Coronavirus Disease 2019 (COVID-19) pandemic has not been studied.

METHODS: We have assessed PPE availability among dermatologists and relevant aspects of hospital service by surveying 733 dermatologists.

RESULTS: Considerable percentages of respondents had to purchase their own PPE (40.2%) and were not provided with it at the hospital (37.7%). Only 27% of respondents provided hospital service, and 18.4% were assigned to nondermatologic duty. A substantial percentage (64.4%) indicated the availability of hospital-issued management guidelines (HIMG) for COVID-19 patients. Nearly half of the survey participants (49.1%) responded that the health care system was not equipped for the pandemic. Purchasing one's own PPE was strongly associated with the private practice setting and continent, with the highest rates in Central and South America and in Europe (P < .001). PPE availability at a hospital was associated with 2 continents, with the highest rates in Europe and in North America (P < .001). In logistic regression, the most important factor reducing the odds ratio (OR) for purchasing their own PPE was HIMG for COVID-19 patients (OR, 0.55; 95% confidence interval [CI], 0.32-0.97). Respondents' assessment that the health care system was equipped for COVID-19 was the most powerful increaser of OR for PPE availability (OR, 9.43; 95% CI, 5.37-16.56) followed by >1,000 COVID-19 cases in a participant's country.

CONCLUSIONS: Substantial percentages of respondents had to purchase their own PPE and were not provided with it at the hospital. Strategies to increase PPE availability should be implemented by hospitals, industry, and government authorities.

Copyright © 2021 Elsevier Ltd. All rights reserved.

Conflict of interest statement

Declaration of Competing Interest The authors declare no conflicts of interest.

References

  1. JAMA. 2016 Aug 2;316(5):533-4 - PubMed
  2. Dermatol Ther. 2020 Jul;33(4):e13723 - PubMed
  3. Dermatol Ther. 2020 Jul;33(4):e13470 - PubMed
  4. Hosp Pract (1995). 2020 Dec;48(5):246-247 - PubMed
  5. Dermatol Ther. 2020 Jul;33(4):e13773 - PubMed
  6. Dermatol Ther. 2020 Jul;33(4):e13758 - PubMed
  7. Dermatol Ther. 2020 Sep;33(5):e13521 - PubMed
  8. J Thorac Dis. 2017 Jun;9(6):1725-1729 - PubMed
  9. Pulmonology. 2020 Jul - Aug;26(4):204-212 - PubMed
  10. J Glob Health. 2020 Jun;10(1):010345 - PubMed
  11. J Eur Acad Dermatol Venereol. 2020 May;34(5):e213-e214 - PubMed
  12. J Am Acad Dermatol. 2020 May;82(5):e179-e180 - PubMed
  13. Br J Dermatol. 2020 Jun;182(6):1477-1478 - PubMed
  14. Dermatol Ther. 2020 Jul;33(4):e13638 - PubMed
  15. JAMA. 2020 May 19;323(19):1912-1914 - PubMed
  16. N Engl J Med. 2020 May 21;382(21):2049-2055 - PubMed
  17. Am J Emerg Med. 2020 Sep;38(9):1727-1731 - PubMed
  18. Br J Oral Maxillofac Surg. 2020 Jun;58(5):500-502 - PubMed
  19. Cureus. 2020 Apr 4;12(4):e7538 - PubMed
  20. J Eur Acad Dermatol Venereol. 2020 Jun;34(6):1196-1201 - PubMed
  21. J Am Acad Dermatol. 2020 Apr;82(4):1034 - PubMed
  22. Indian J Crit Care Med. 2020 May;24(5):369-370 - PubMed
  23. J Eur Acad Dermatol Venereol. 2020 Jul;34(7):1388-1394 - PubMed
  24. JMIR Public Health Surveill. 2020 Apr 16;6(2):e18980 - PubMed
  25. Dermatol Ther. 2020 Sep;33(5):e13420 - PubMed
  26. J Am Acad Dermatol. 2020 Jul;83(1):e53-e54 - PubMed
  27. BMJ. 2020 Apr 17;369:m1507 - PubMed
  28. Dermatol Ther. 2020 Sep;33(5):e13430 - PubMed
  29. J Eur Acad Dermatol Venereol. 2020 May;34(5):e210-e211 - PubMed
  30. Recenti Prog Med. 2020 Apr;111(4):183 - PubMed
  31. Dermatol Ther. 2020 Jul;33(4):e13523 - PubMed
  32. Dermatol Ther. 2020 Jul;33(4):e13472 - PubMed
  33. Infect Control Hosp Epidemiol. 2021 Jun;42(6):786-787 - PubMed

MeSH terms

Publication Types